Correlation Between Lactate Dehydrogenase (LDH) Values and Aspects Score at the Beginning of Treatment in Acute Ischemic Stroke

Authors

  • Lathifatul Fikriyah Universitas Airlangga, Indonesia

DOI:

https://doi.org/10.46799/jhs.v6i7.2656

Keywords:

Acute ischemic stroke, ASPECTS Score, Lactat Dehidrogenase

Abstract

Stroke is the second leading cause of death worldwide, with ischemic stroke comprising 87% of cases. Metabolic acidosis from hypoxia promotes anaerobic glycolysis, raising lactate dehydrogenase (LDH) levels, which reflects neuronal tissue injury and inflammation in acute ischemic stroke. The Alberta Stroke Program Early CT Score (ASPECTS) is used to assess ischemic brain injury on non-contrast CT, aiding early prognosis and treatment decisions. This cross-sectional study at Dr. Soetomo Hospital, Surabaya (February–May 2023), included 30 acute ischemic stroke patients (53.3% male, mean age 60.2 ± 7.1 years, onset 2–5 days). Exclusion criteria were prior thrombolysis, cancer, or organ failure. LDH levels were measured at admission using the Alinity C analyzer, and ASPECTS was calculated from initial CT scans. Spearman’s correlation was used for analysis. Results showed a significant inverse correlation between LDH and ASPECTS (r = -0.279, p = 0.003), indicating that higher LDH levels correspond with lower ASPECTS (larger infarcts). Mean LDH was elevated (258.75 ± 50.65 U/L, normal 120–190 U/L). Comorbidities included hypertension (90%), dyslipidemia (83.3%), and diabetes mellitus (56.7%). These findings suggest that serum LDH may be a valuable adjunct biomarker for early assessment of ischemic stroke severity when advanced imaging is unavailable, helping clinicians estimate infarct size rapidly. Further research involving larger populations is recommended to confirm LDH’s utility and to examine its combination with other biomarkers for acute ischemic stroke management.

References

Brouns, R., Sheorajpanday, R., Wauters, A., De Smet, S., De Deyn, P. P., & Marien, P. (2008). Evaluation of lactate as a marker of metabolic stress and cause of secondary damage in acute ischemic stroke or TIA. Clinical Chemistry and Laboratory Medicine, 397(1-2), 27–31.

Eren, F., Demir, A., & Eren, G. (2021). Association between the initial blood lactate level and prognosis in patients with stroke treated with intravenous thrombolysis. Annals of Medical Research, 28(6), 996.

Esmael, A., Elsherief, M., & Eltoukhy, K. (2021). Predictive value of the Alberta Stroke Program Early CT Score (ASPECTS) in the outcome of the acute ischemic stroke and its correlation with stroke subtypes, NIHSS, and cognitive impairment. Stroke Research and Treatment, 2021, 5935170. https://doi.org/10.1155/2021/5935170

Genc, S., Kurnaz, I. A., & Ozilgen, M. (2011). Astrocyte-neuron lactate shuttle may boost more ATP supply to the neuron under hypoxic conditions—in silico study supported by in vitro expression data. BMC Systems Biology, 5(1), 162. https://doi.org/10.1186/1752-0509-5-162

Hartings, J. A., Shuttleworth, C. W., Kirov, S. A., Shin, H. K., Dirnagl, U., Faraj, J. J., & Dreier, J. P. (2017). The continuum of spreading depolarizations in acute cortical lesion development: examining Leão’s legacy. Journal of Cerebral Blood Flow & Metabolism, 37(5), 1571–1594.

Jin, H., Bi, R., Hu, J., Jiang, S., Zhang, W., Chen, J., & Li, R. (2022). Elevated serum lactate dehydrogenase predicts unfavorable outcomes after rt-PA thrombolysis in ischemic stroke patients. Frontiers in Neurology, 13, 1–10.

Jin, H., Zhou, J., Dong, F., & Tan, J. (2020). A combination of serum lactate dehydrogenase and sex is predictive of severe disease in patients with COVID-19. Medicine, 99(42), e22774.

Jin, X. X., Fang, M. D., Hu, L. L., Zhu, S. D., & Yu, W. S. (2022). Elevated lactate dehydrogenase predicts poor prognosis of acute ischemic stroke. PLOS ONE, 17(10), e0275651.

Khoshnam, S. E., Winlow, W., Farzaneh, M., Khoshnam, M., & Zendedel, A. (2017). Pathogenic mechanisms following ischemic stroke. Neurological Sciences, 38(7), 1167–1186.

Lampl, Y., Paniri, Y., Eshel, Y., & Sadeh, M. (1990). Cerebrospinal fluid lactate dehydrogenase levels in early stroke and transient ischemic attacks. Stroke, 21(6), 854–857.

Mansour, A. M., El-Kady, H. S., El-Sayed, A. I., & El-Toukhy, K. I. (2020). Serum lactate dehydrogenase as a predictive marker in acute ischemic stroke. Neurological Sciences, 41(9), 2419–2424. https://doi.org/10.1007/s10072-020-04534-z

Schröder, J., & Thomalla, G. (2017). A critical review of Alberta Stroke Program Early CT Score for evaluation of acute stroke imaging. Frontiers in Neurology, 7, 1–7.

Tan, Y., Wang, X., Wang, Y., Yu, D., Wang, X., Hou, Y., & Chen, J. (2021). Lactate dehydrogenase: a novel biomarker in stroke pathology and prognosis. Neurochemical Research, 46(3), 562–573. https://doi.org/10.1007/s11064-020-03100-x

Valvona, C. J., Fillmore, H. L., Nunn, P. B., & Kendall, D. A. (2016). The regulation and function of lactate dehydrogenase A: therapeutic potential in brain tumor. Brain Pathology, 26(1), 3–17.

Virani, S. S., Alonso, A., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., ... & Tsao, C. W. (2020). Heart disease and stroke statistics—2020 update: a report from the American Heart Association. Circulation, 141(9), e139–e596. https://doi.org/10.1161/CIR.0000000000000757

Wang, A., Tian, X., Zuo, Y., Lin, X., Deng, H., Chen, X., & Liu, Q. (2021). High lactate dehydrogenase was associated with adverse outcomes in patients with acute ischemic stroke or transient ischemic attack. Annals of Palliative Medicine, 10(10), 10185–10195.

Wang, Y., Fang, M. D., Jin, X. X., Hu, L. L., Zhu, S. D., & Yu, W. S. (2022). Elevated lactate dehydrogenase predicts poor prognosis of acute ischemic stroke: a population-based cohort study. PLOS ONE, 17(10), e0275651.

World Health Organization. (2021). The top 10 causes of death. https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death

Zhang, Q., Song, X., Li, X., Wang, Q., Liu, Y., & Song, W. (2023). Serum level of lactate dehydrogenase is associated with stroke severity and prognosis in acute ischemic stroke. Frontiers in Neurology, 14, 1111166. https://pmc.ncbi.nlm.nih.gov/articles/PMC8742599/

Zhao, H., Li, X., Zhang, T., Yang, H., & Chen, Y. (2021). Combined use of serum biomarkers and ASPECTS score improves prediction of clinical outcomes after acute ischemic stroke. Journal of Stroke and Cerebrovascular Diseases, 30(12), 105682.

Downloads

Published

2025-07-17